Pheochromocytoma (PHEO) coexisting ipsilaterally with primary aldosteronism (PA)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adrenalectomy has been completed; 2.Preoperative diagnosis was primary aldosteronism; 3.Postoperative pathology indicated coexistence of ipsilateral adrenal pheochromocytoma and aldosterone-producing nodule; 4.Somatic VHL mutation has been detected in the pheochromocytoma tissue; 5.Patient provided informed consent.
Exclusion criteria
Exclusion criteria: 1.Postoperative tissue quality does not meet the requirements for analysis; 2.No valid pathological regions are available for laser microdissection or multi-omics research; 3.Patient refused to sign or withdrew informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Regional mutational profile and variant allele frequency;Spatial expression and gradient of key proteins; | — |
Secondary
| Measure | Time frame |
|---|---|
| Spatial correlation indices;Changes in CYP11B2 mRNA/protein expression; | — |
Countries
China
Contacts
Fuzhou University Affiliated Provincial Hospital